Sight Sciences
Total Raised
$140MInvestors Count
8Deal Terms
2Funding, Valuation & Revenue
10 Fundings
Sight Sciences has raised $140M over 10 rounds.
Sight Sciences's latest funding round was a IPO for $240M on July 16, 2021.
Sight Sciences's latest post-money valuation is from July 2021.
Sign up for a free demo to see Sight Sciences's valuations in July 2021 and more.
Sight Sciences's 2020 revenue was $27.64M. Sight Sciences's most recent revenue is from 2020.
Sign up for a free demo to see revenue data from 2020 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/16/2021 | IPO | $240M | 1 | |||
12/10/2020 | Series F | $23.25M | $27.64M (15.95x) FY 2020 | 1 | ||
5/3/2020 | Loan | $3.5M | ||||
3/18/2020 | Series E | |||||
9/4/2019 | Line of Credit |
Date | 7/16/2021 | 12/10/2020 | 5/3/2020 | 3/18/2020 | 9/4/2019 |
|---|---|---|---|---|---|
Round | IPO | Series F | Loan | Series E | Line of Credit |
Amount | $240M | $23.25M | $3.5M | ||
Investors | |||||
Valuation | |||||
Revenue | $27.64M (15.95x) FY 2020 | ||||
Sources | 1 | 1 |
Sight Sciences Deal Terms
2 Deal Terms
Sight Sciences's deal structure is available for 2 funding rounds, including their IPO from July 16, 2021.
Round | IPO | Series B |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series B |
Sight Sciences Investors
8 Investors
Sight Sciences has 8 investors. Scientific Health Development invested in Sight Sciences's Series F funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/28/2011 | 12/10/2020 | 6 Series A, Series B (2015), Series C (2017), Series C - II (2018), Series D (2019), Series F (2020) | Venture Capital | Texas | ||
Venture Capital | California | |||||
Government | DC | |||||
Asset/Investment Management | New York | |||||
Debt & Specialty Finance | Maryland |
First funding | 9/28/2011 | ||||
|---|---|---|---|---|---|
Last Funding | 12/10/2020 | ||||
Investor | |||||
Rounds | 6 Series A, Series B (2015), Series C (2017), Series C - II (2018), Series D (2019), Series F (2020) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Government | Asset/Investment Management | Debt & Specialty Finance |
Location | Texas | California | DC | New York | Maryland |
Loading...